Perspectives on Brain-Targeting Drug Delivery Systems

Author(s): Liangran Guo, Jinfeng Ren, Xinguo Jiang

Journal Name: Current Pharmaceutical Biotechnology

Volume 13 , Issue 12 , 2012

Become EABM
Become Reviewer
Call for Editor


Due to the presence of the blood-brain barrier, there is limited drug access into the brain. In order to overcome this challenge, various strategies have been developed to enhance penetration of drugs into the brain. Of these, the most frequently used are pharmacological technologies or comparable methods being developed for brain-targeting drug delivery using receptor- or adsorptive- or transporter-mediated transcytosis and the nose-to-brain route. It goes without saying that exploration of Brain-targeting drug delivery systems has created another potential option for the treatment of central nervous system diseases. In addition to above methods, other technologies for brain-targeting drug delivery (e.g. chemical delivery systems, prodrugs, pharmacological disruption of the BBB and inhibition of drug efflux by P-glycoprotein) are also summaried in this review.

Keywords: Blood-brain barrier, brain-targeting drug delivery systems, receptor-mediated transcytosis, adsorptive-mediated transcytosis, transporter-mediated transcytosis, nose-to-brain, chemical delivery systems, prodrugs, P-glycoprotein, Targeting drug delivery, colloidal drug, harmful blood-borne substances, small molecule drugs, endothelium cells

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 05 October, 2012
Page: [2310 - 2318]
Pages: 9
DOI: 10.2174/138920112803341770
Price: $65

Article Metrics

PDF: 33